Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Hamadani

Showing results (21-30 of 459) with videos related to

Pageof 46
Sort By:
Clinical Advances in Hematology & Oncology : H&O|May 23, 2008
Review: isolated skeletal involvement in hairy cell leukemiaMehdi Hamadani, Eric H Kraut
Hematological Oncology|October 10, 2012
Rituximab maintenance versus retreatment in follicular lymphomaAmruth R Palla, Mehdi Hamadani
Annals of Hematology|May 1, 2007
Paraneoplastic Sweet's syndrome and the pathergy phenomenonFarrukh Awan, Mehdi Hamadani, Steven Devine
Expert Review of Hematology|August 6, 2025
Reduced-intensity conditioning for allogeneic transplantation in classical Hodgkin lymphomaHiba Narvel, Gulrayz Ahmed, Mehdi Hamadani
British Journal of Haematology|September 22, 2016
Think outside the box: Acanthamoeba encephalitis following autologous haematopoietic stem cell transplantationNarendranath Epperla, Horatiu Olteanu, Mehdi Hamadani
Ejhaem|January 6, 2022
New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCLMadiha Iqbal, Bipin N Savani, Mehdi Hamadani
Expert Opinion on Pharmacotherapy|September 12, 2018
Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphomaHamza Hashmi, Mehdi Hamadani, Farrukh T Awan
Expert Opinion on Biological Therapy|January 11, 2025
The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphomaGulrayz Ahmed, Mehdi Hamadani, Taha Al-Juhaishi
Expert Opinion on Investigational Drugs|July 8, 2024
New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literatureNa Hyun Kim, Mehdi Hamadani, Sameem Abedin
The New England Journal of Medicine|October 1, 2015
Ibrutinib in Refractory Classic Hodgkin's LymphomaMehdi Hamadani, Sriram Balasubramanian, Parameswaran N Hari
Pageof 46

Showing results (21-30 of 459) with videos related to

Sort By:
Pageof 46
Clinical Advances in Hematology & Oncology : H&O|May 23, 2008
Review: isolated skeletal involvement in hairy cell leukemiaMehdi Hamadani, Eric H Kraut
Hematological Oncology|October 10, 2012
Rituximab maintenance versus retreatment in follicular lymphomaAmruth R Palla, Mehdi Hamadani
Annals of Hematology|May 1, 2007
Paraneoplastic Sweet's syndrome and the pathergy phenomenonFarrukh Awan, Mehdi Hamadani, Steven Devine
Expert Review of Hematology|August 6, 2025
Reduced-intensity conditioning for allogeneic transplantation in classical Hodgkin lymphomaHiba Narvel, Gulrayz Ahmed, Mehdi Hamadani
British Journal of Haematology|September 22, 2016
Think outside the box: Acanthamoeba encephalitis following autologous haematopoietic stem cell transplantationNarendranath Epperla, Horatiu Olteanu, Mehdi Hamadani
Ejhaem|January 6, 2022
New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCLMadiha Iqbal, Bipin N Savani, Mehdi Hamadani
Expert Opinion on Pharmacotherapy|September 12, 2018
Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphomaHamza Hashmi, Mehdi Hamadani, Farrukh T Awan
Expert Opinion on Biological Therapy|January 11, 2025
The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphomaGulrayz Ahmed, Mehdi Hamadani, Taha Al-Juhaishi
Expert Opinion on Investigational Drugs|July 8, 2024
New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literatureNa Hyun Kim, Mehdi Hamadani, Sameem Abedin
The New England Journal of Medicine|October 1, 2015
Ibrutinib in Refractory Classic Hodgkin's LymphomaMehdi Hamadani, Sriram Balasubramanian, Parameswaran N Hari
Pageof 46